寻找肌萎缩侧索硬化起病部位的共识
本文探讨肌萎缩侧索硬化(ALS)的起源问题,讨论ALS与额颞叶痴呆(FTD)在TAR DNA结合蛋白43代谢、遗传变异和胶质反应等方面的共同点,并介绍由离散神经网络功能障碍驱动皮质与皮质下功能障碍的假说,提出共享分子脆弱性可能是理解ALS及其治疗进展的关键。
要点
- ALS与FTD共享TAR DNA结合蛋白43代谢改变及RNA结合蛋白病理聚集。
- 两种疾病共享多个疾病相关或疾病修饰遗传变异,提示共同机制。
- 新假说认为皮质与皮质下功能障碍由离散神经网络受损驱动,共享分子脆弱性是关键。
核心结论
- ALS与FTD的共现反映的是共享分子脆弱性而非独特神经解剖对应关系,共享脆弱性的基础将成为理解ALS及其可能治疗进展的关键。
研究设计与样本
- 本文为综述,检索范围原文未报告。
主要发现
- ALS与FTD均显示TAR DNA结合蛋白43代谢改变,表现为核细胞质定位偏移及由RNA结合蛋白病理聚集构成的广泛神经元胞质包涵体。
- 两种疾病共享多个疾病相关或疾病修饰遗传变异,提示共同 underlying 机制。
- 两种疾病中均推测存在显著的胶质反应参与非细胞自主性扩散。
- 较新的假说认为皮质与皮质下功能障碍综合征由离散神经网络受损驱动,这些网络对单一分子毒性或其组合具有独特且选择性的脆弱性。
- ALS与FTD中一个或多个网络功能障碍的共现反映的是共享分子脆弱性而非独特神经解剖对应关系。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The fundamental origin of amyotrophic lateral sclerosis (ALS) has remained an enigma since its earliest description as a relentlessly progressive degeneration with prominent neuromuscular manifestations that are associated with upper and lower motor neuron dysfunction. Although this remains the hallmark of ALS, a significant proportion of patients will also demonstrate one or more features of frontotemporal dysfunction, including a frontotemporal dementia (FTD). Understanding whether these 2 seemingly disparate syndromes are simply reflective of the co-occurrence of 2 distinct pathologic processes or the clinical manifestations of a common pathophysiologic derangement involving the brain more widely has gripped contemporary ALS researchers. Supporting a commonality of causation, both ALS and FTD show an alteration in the metabolism of TAR DNA-binding protein 43, marked by a shift in nucleocytoplasmic localization alongside a broad range of neuronal cytoplasmic inclusions consisting of pathologic aggregates of RNA-binding proteins. Similarly, several disease-associated or disease-modifying genetic variants that are shared between the 2 disorders suggest shared underlying mechanisms. In both, a prominent glial response has been postulated to contribute to non-cell-autonomous spread. A more contemporary hypothesis, however, suggests that syndromes of cortical and subcortical dysfunction are driven by impairments in discrete neural networks. This postulates that such networks, including networks subserving motor or cognitive function, possess unique and selective vulnerabilities to either single molecular toxicities or combinations thereof. The co-occurrence of one or more network dysfunctions in ALS and FTD is thus a reflection not of unique neuroanatomic correlates but rather of shared molecular vulnerabilities. The basis of such shared vulnerabilities becomes the fulcrum around which the next advances in our understanding of ALS and its possible therapy will develop.
引用
- Strong MJ, Swash M. Finding Common Ground on the Site of Onset of Amyotrophic Lateral Sclerosis. Neurology. 2022. PMID: 36261296. doi:10.1212/WNL.0000000000201387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。